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Summary
The three-dimensional structure of an unglycosylated T cell antigen receptor (TCR) R chain
has recently been determined to 1 .7 A resolution. To investigate whether this soluble R chain
(murine V(38.2JR2.IC(31) retains superantigen (SAG)-binding activity, we measured its affinity
for various bacterial SAGS in the absence of MHC class II molecules. Dissociation constants
(KDs) were determined using two independent techniques: surface plasmon resonance detec-
tion and sedimentation equilibrium. Specific binding was demonstrated to staphylococcal en-
terotoxins (SEs) B, C1, C2, and C3 and to streptococcal pyrogenic exotoxin A (SPEA), consis-
tent with the known proliferative effects of these SAGs on T cells expressing V(38.2. In contrast,
SEA, which does not stimulate V(38.2-bearing cells, does not bind the recombinant R chain.
Binding of the R chain to SAGs was characterized by extremely fast dissociation rates (>0.1
s-1), similar to those reported for certain leukocyte adhesion molecules. Whereas the R chain
bound SEC1, 2, and 3 with KDs of 0.9-2.5 [LM, the corresponding value for SEB was ^140
p,M. The much weaker binding to SEB than to SEC1, 2, or 3 was surprising, especially since
SEB was found to actually be 3- to 10-fold more effective, on a molar basis, than the other tox-
ins in stimulating the parental T cell hybridoma. We interpret these results in terms ofthe abil-
ity of SEC to activate T cells independently of MHC, in contrast to SEB. We have also mea-
sured SE binding to the glycosylated form of the R chain and found that carbohydrate apparently
does not contribute to recognition, even though the N-linked glycosylation sites at V(38.2 res-
idues Asn24 and Asn74 are at or near the putative SAG-binding site. This result, along with the
structural basis for the V(3 specificity of SEs, are discussed in relation to the crystal structure of
the unglycosylated R chain.
Antigen recognition by T lymphocytes is mediated by
highly diverse cell surface glycoproteins known as T
cell receptors (TCRs)t. In addition to recognizing peptide
antigens complexed with products of the MHC complex,
TCRs interact with a class of molecules known as superan-
tigens (SAGs), which stimulate T cellsbearing particular V(3
'Abbreviations used in this paper: APC, antigen-presenting cell; RCHO,
glycosylated 13 chain; (3mut, unglycosylated 13 chain; HBS, Hepes-buff
ered saline; Kp, dissociation constant; Ms, minor lymphocyte stimulating
antigen; r, correlation coefficient; RU, response unit; SAG, superantigen;
SEA, staphylococcal enterotoxin A; SEB, staphylococcal enterotoxin B;
SEC, staphylococcal enterotoxin C; SEE, staphylococcal enterotoxin E;
SPEA, streptocococcal pyrogenic exotoxin A; TCR, T cell antigen re-
ceptor.
regions, largely irrespective of the peptide/MHC specific-
ity of the TCR (1-3) . SAGs include self antigens, such as
the minor lymphocyte stimulating antigens (Mls) encoded
by endogenous murine retroviruses, as well as foreign anti-
gens, such as staphylococcal and streptococcal pyrogenic
toxins.
T cell stimulation by SAGs is generally thought to re-
quire the participation of MHC class 11 molecules (4-8),
which bind some bacterial SAGs with affinities in the mi-
cromolar range (9-12). Most current models assume that
SAGs activate T cells by simultaneously binding class lI mol-
ecules on APC and the VR element on T cells (1-3, 13) .
Recently, however, through the use of class 11 knockout
mice, staphylococcal enterotoxin C (SEC) and staphylococ-
cal enterotoxin E (SEE) have been shown to activate T cells
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conventional class 11-associated one in that T cells express-
ing the same V(3 gene segment were selectively stimulated.
However, T cell activation by SEC and SEE in MHC-
deficient mice was not followed by deletion ofclones bear-
ing the relevant V(3 element. Thus, MHC-independent T
cell activation may produce certain physiological conse-
quences whichare different from those associated with MHC-
dependent activation.
To investigate the biochemical basis of T cell activation
by SAGS, we have measured the binding of various bacte-
rial toxins to a soluble murine TCR R chain (V(38.2J(32.1
C(31) in the absence ofMHC class 11 molecules. As we have
recently determined the three-dimensional structure of this
(3 chain to atomic resolution (15), this represents an excel-
lent system fordelineating TCR-SAG interactions. We show
that the reactivity of this R chain toward different toxins is
consistent with theireffectson the parental Tcell hybridoma.
We also find that the ability ofcertain bacterial SAGs to ac-
tivate T cells independently of MHC correlates with the
relatively high affinity of these particular toxins for the iso-
lated (3 chain. By measuring the affinity of glycosylated and
unglycosylated forms of the R chain for SEs, we have been
able to directly assess the contribution of carbohydrate to
SAG binding. Finally, the identification of amino acid resi-
dues on the putative SAG-binding surface ofthe VP8.2 do-
main which are conserved in other V(3 domainswith similar
or different toxin reactivities provides insights into the struc-
tural basis ofTCR recognition by SAGS.
Materials and Methods
Superantigens.
￿
Purified SEA, SEB, SEC1, SEC2 and SEC3 were
purchased from Toxin Technology, Inc. (Sarasota, FL). Strepto-
coccal pyrogenicexotoxin A (SPEA) wasprepared as described (16) .
Recombinant TCR Proteins.
￿
The soluble a(3 TCRused is a chi-
mericmolecule in which theV andextracellular C regions ofboth
a and (3 chains were fused with immunoglobulin Cic regions
(17) . The TCR (designated 14.3.d) is specific for a hemagglutinin
peptide of influenza virus (HA 110-120) in the context of I-Ed
and utilizes the Va4.1Ja2134/V(38.2J(32.1 gene combination (18) .
The chimeric protein is assembled and secreted as a functional,
glycosylated VaCUCic/V(3CRCic heterodimer by J558L my-
eloma cells transfected with the recombinant genes (17). Affinity
purification using the anti-mouse Cic monoclonal antibody 187.1
(19) was carried out as described (17).
Glycosylated 14.3.d V(3C(3 chain ((3CHO) was derived from
the VaCaCic/V(3C(3Cic heterodimer by treatment with papain,
which wasfound to selectively degrade the a chain as well as both
Crc domains (20). In a typical preparation, oa/3 heterodimer at a
concentration of2 mg/ml in 0.1 M KP04, pH 7.2, was digested
for 35 min at 37°Cwith papain (Worthington) at an enzyme/sub-
strate ratio of 1:500 in the presence of 1.25 mM EDTA and 1.5
mM 2-mercaptoethanol. The reaction was terminated by the ad-
dition ofN-ethylmaleimide to afinal concentration of 10 MM.
Unglycosylated VRCR chain ((3mut) was obtained by elimina-
tion of four out of five potential N-linked glycosylation sites
through site-directed mutagenesis and introduction of a termina-
tion codon at the end of the first C region exon of the (3 chain
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(15) . Asparagines at positions 24, 74, and 121 (numbering accord-
ing to reference 21) were mutated to glutamine, while the glyco-
sylation site at position 236was eliminated by mutation of Ser238
to valine. The Rmut chainwas produced in J558L cellsand affinity
purified usingthe anti-mouse C(3 monoclonal antibody H57-597
(15, 22). The unmutated N-linked glycosylation site at position
C(3 186 was used in <10"/o ofthe chains, as judged by SDS-PAGE.
The bacterially produced Vac domain of a TCR (designated
1934.4) specific forthe NHZ-terminal nonapeptide of myelin ba-
sicprotein presentedby I-A° (23) was kindly provided by Dr. E. S.
Ward (Southwestern Medical School, Dallas, TX). The His,-
tagged protein was purified by Nit+-NTA agarose and anion ex-
change chromatography as described (23, 24).
BlAcore Analysis.
￿
The interaction of soluble TCR fragments
with immobilized SAGS was monitored with a BIAcore instru-
ment (Pharmacia Biosensor, Uppsala, Sweden). All proteins were
purified by gel filtration on a Superose 12 FPLC column (Phar-
macia) before use to eliminate aggregated material that could in-
terfere with affinity measurements (25, 26). Typically, <5% of
the SAG or TCR preparations eluted at or near the void volume .
SAGS were coupled to the dextran matrix o£ CM5 sensor chips
(Pharmacia) using the Amine Coupling Kit as described (27).
SEC1, SEC2, SEC3, SEB, and SEA, which have isoelectric
points above 7.0 (16), were dialyzed against 10 mM sodium ace-
tate, pH 5.5. SPEA, whose isoelectric point is -5.0 (16), was di-
alyzed against 10 mM sodium acetate, pH 4.2. Protein concentra-
tions ranged from 50 to 150 ltg/ml. The activation and
immobilization periods were set to between 2 and 7 min to cou-
ple the desired amount of SAG. Recombinant TCR fragments
were dialyzed against Hepes-buffered saline (HBS) containing
150 mM NaCl, 0.005% Surfactant P-20 (Pharmacia), 10 mM
Hepes, pH 7.5; dilutions were made in the same buffer. All bind-
ing experiments were performed at 25°C. Dissociation was car-
ried outin HBS. Flow ratesare given in thefigure legends. Pulses
of 10 mM HCl were used to regenerate the surfaces. Runs were
analyzed using the software BIAevaluation 2.0 (Pharmacia). Dis-
sociation constants (KDs) were determined under equilibrium
binding conditions using Scatchard analysis (28). Standard devia-
tions for three or more independent determinations were <8%.
Sedimentation Equilibrium.
￿
Equilibrium sedimentation of the
Rmut chain, the various SAGS, and their mixtures were per-
formed with a Beckman XL-A Optima analytical ultracentrifuge
using a four-hole, An-55 rotor. All experiments were performed
between 20-25°C at rotor speeds of between 22,000 to 30,000
rpm. The molar extinction coefficients used were: Omit, 43,200
M-lcm-1; SEB, 40,500 M-Icm-t; SEC1, 34,200 M-1cm-1;
SEC2, 34,200 M-'cm-'; SEC3, 34,200 M-1cm-' ; SPEA, 29,900
M-1cm-'. The concentration distributions of the samples at sedi-
mentation equilibrium were acquired either as a single measure-
ment or as an average of25 measurements of absorbance at each
radial position, with nominal spacing of 0.001 cm between radial
positions. Samples were prepared by dialysis against either 50 mM
Tris-HCI, pH 7.0, or 0.1 M sodium phosphate, pH 7.2. Partial
specific volumes for the R chain and the toxins were assumed to
be 0.73 ml/mg, and solvent densities were determined pychno-
metrically.
Equilibrium sedimentation data on the individual (3 chain and
individual SAGs obtained either at two different rotor speeds or
two initial protein concentrations were analyzed for average mo-
lecular weights in termsofa single, homogeneous species accord-
ing to
c, = B+cmexp[M(1-pp)&j2 (r2 -rm2)12RT]
￿
(1)where c, is the concentration ofthe protein at a given radial posi-
tion, cm is the concentration of the protein at some reference po-
sition (e.g., the meniscus), M is the molecular weight, v is the par-
tial specific volume, p is the solvent density, Co is the angular
velocity, r is the radial position in centimeters from the center of
rotation, r, is the distance in centimeters from the center ofrota-
tion to the meniscus, R is the gas constant, Tis the absolute (Kelvin)
temperature, and B is a correction term for a nonzero baseline.
Equilibrium constants for the association of the [3 chain and
SAGS were calculated from the data obtained at sedimentation
equilibrium according to
where c,,R is the concentration of receptor at the reference posi-
tion, c., T is the concentration of the toxin at the reference posi-
tion, MR and MT are the molecular weights of the Pmut chain
and SAGS as determined in separate sedimentation equilibrium
experiments, Mc is the molecular weight ofthe complex, and KD
is the dissociation constant for the various [3 chain-SAG interac-
tions. Parameters were evaluated using nonlinear least-squares anal-
ysis (29), or by using a modified version of IGOR (Wavemetrics,
Lake Oswego, OR) running on a Macintosh computer (30, 31) .
Data for two different concentrations or two rotor speeds were
analyzed simultaneously as a test for homogeneity and reversibil-
ity (32) and to constrain confidence intervals for the parameter
values (33). Errors on KDs were -20% of parameter values.
T Cell Stimulation Assay.
￿
T cell stimulation was monitored by
the release of IL-3 as previously described (34). Briefly, 5 X 104
irradiated (10,000 rad) A20 APC were preincubated with differ-
ent concentrations of SAGS or positive control peptide (HA 110-
119) in 100-N.1 volumes for 2 h in 96-well plates. Thereafter, 2 X
104 14.3.d T cell hybridoma cells were added in 100-WI volumes
and supernatants were harvested 20 h later for assay of IL-3 activ-
ity. Proliferation of the IL-3-dependent cell line DA-1 was mea-
sured 26 h later using [3H]thymidine. All measurements were done
in duplicate in the presence of 5% FCS in IMDM culture media.
Results
cT=B+cm,R exp[MR (1 -vr)to (r2
-rmz)l2RT]+
(cm, T) exp [MT(1 - vr) o) (r2 -
rm2)
/2 R T] +
￿
(2)
(Cm R)
(CV1,T)/KDexp [MC (1 - vp) co2 (rz - rm2) /2 RT]
The Binding ofSoluble TCR Components to SAGS Is Char-
acterized by Rapid Association and Dissociation Rates. To ana-
lyze the interaction of recombinant TCR molecules with
SAGs by BIAcore, SAGS were coupled directly to the dex-
tran matrix through primary amine groups of the proteins
(27). Injection ofdifferent concentrations of 14.3.d otp TCR,
RCHO, and Pmut over SEC1 gave concentration-depen-
dent binding (Fig. 1, A, B, and C, respectively) that can be
distinguished from the profile obtained when SEA was im-
mobilized (Fig. 1 E). Results similar to those for SEC1
were obtained when SEC2, SEC3, and SPEA were cou-
pled to the matrix (not shown). These data are in agree-
ment with the ability of SEC and SPEA, but not SEA, to
stimulate VR8.2-bearing T cells (2). Surprisingly, the bind-
ing to SEB, which is also known to activate cells expressing
V(38.2 (2), appeared markedly weaker: whereas injection of
8 RIVI Pmut over 4,000 response units (RU) of immobi-
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lized SEC1 produced a total response (specific and nonspe-
cific; see below) of-1,750 RU (Fig. 1 C), injection of the
same concentration of R chain over 4,000 RU of immobi-
lized SEB resulted in a response of only about 400 RU
(Fig. 1 F) . Similarly, injection of 8 u,M otp TCR over SEB
produced a response of only -200 RU (Fig. 1 G), indicat-
ing that the weak interaction of Rmut with this toxin is not
due to the absence of carbohydrate or ofa chain. Injection
of 8 N.M 1934.4 Vot over SEC1 produced a response (Fig.
1 D) similar to that observed after injection of Pmut over
SEA (Fig. 1 E).
Efforts to examine binding in the reverse orientation
(i.e., with TCR components on the sensor surface and
SAGS in solution) were not successful. In the case of a(3
TCR, although binding of SEC was detectable, baseline drift
precluded quantitative analysis; similar difficulties have been
reported for the binding of SEB to an immobilized human
TCR (12) . In the case of (3CHO and (3mut, no binding of
any SAG could be detected, implying that immobilization
of the (3 chain through amine groups led to its inactivation,
as described in other systems (26). These difficulties prompted
us to measure (3 chain-SAG interactions by sedimentation
equilibrium (see below), which does not require ligand im-
mobilization.
When 8 R1VI aR TCR were injected over SEC1, SEC2,
SEC3, and SPEA, the response occurred in two distinct
phases: a fast initial increase of -800 RU, followed by a
much slower increase of -300 RU (Fig. 1 A, for the case
of SEC1) . When buffer flow was reestablished, the re-
sponse dropped in two phases: a fast initial drop of -800
RU within 4 s, followed by a slower decrease over the re-
maining 300 RU. We attribute the slowly dissociating phase
to the presence ofmultimeric aggregates of up TCR which
bind with high avidity, even though the protein had been
purified by size exclusion chromatography. It has been shown
that even small amounts ofaggregated material (G2%), which
could form during the concentration step after gel filtration,
can produce this type of biphasic dissociation (25, 26) . On
the other hand, when (3CHO or Pmut were injected over
SEC1, SEC2, SEC3, and SPEA, equilibrium binding levels
were reached within seconds (Fig. 1, B and C) . Upon com-
pletion of the injections, the responses dropped rapidly as
well (>90% decrease within the first 4 s in the case of Pmut
dissociating from SEC1 ; Fig. 1 C). Because (3CHO and
Pmut displayed relatively simple kinetic behavior, and be-
cause the reactivity profiles of isolated R chain and up het-
erodimer toward SEC, SPEA, and SEB had been found to
be qualitatively indistinguishable, all subsequent measure-
ments were carried out with RCHO or (3mut. It is worth
noting that the monodisperse behavior of the R chain (see
also below) is consistent with its ability to crystallize: whereas
both RCHO and Pmut have yielded x-ray diffraction qual-
ity crystals, we were unable to crystallize the otp het-
erodimer (15, 20).
The kinetics of the binding of soluble TCR components
to SAGS were too fast to be accurately measured, although
the association and dissociation rate constants may be esti-
mated at >100,000 M-1s-1 and >0 .1 s-1, respectively.h
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Consequently, affinities were determined under equilibrium
binding conditions as described below.
Glycosylated and Unglycosylated TCR 0 Chains Bind SEC
and SPEA with Micromolar Amities. Conditions for equi-
librium binding analysis were chosen on the basis of the ki-
netic behavior of this system (Fig. 1). Approximately 2,000
RU of each SAG were immobilized and buffer flow rates
were set at 5 Ntl/min to avoid diffusion-limited reactions
(28) . Each (3 chain was injected over the surface for 20 s
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and report points for Scatchard analysis were taken 10 s af-
ter injection (Fig. 2) . To estimate apparent Kns, decreasing
concentrations (64, 32, 16, 8, 4, 2, and 1 [1,M) of RCHO or
(3mut were injected over SEA, SEC1, SEC2, SEC3, and
SPEA. To estimate the increase in RU resulting from the
nonspecific effect of protein on the bulk refractive index,
binding of (3CHO and (3mut to a control surface with no
immobilized ligand were also measured (Fig. 2 A). (3CHO
and (3mut showed the same behavior over SEA as over theC
0
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Figure 1.
￿
Concentration-dependent binding of soluble TCR compo-
nents to immobilized SAGS. Binding to SECT by soluble a(3 TCR (A),
PCHO (B), (3mut (C), and Va (D) was recorded at the concentrations
indicated (N,M). Similar profiles were obtained when SEC2, SEC3 and
SPEA were immobilized. In E and F, Pmut was injected over SEA and
SEB, respectively. In (G), up TCR was injected over SEB. For each
SAG, 3,000-5,000 RU were immobilized. The buffer flow rate was 2 N,l/
min and TCR components were injected for 15 min. Dissociation was
carried out for 15 min with HBS and the surfaces were regenerated by in-
jection of 10 mM HCl between assays. Responses are given as increases
over baseline values.
control surface. As an additional control for nonspecific bind-
ing, the same concentrations of an irrelevant protein, BSA,
were injected over a surface with no protein immobilized
(Fig. 2 C) . As can be seen, the response to 32 N.M BSA is
comparable to the response to 64 p,M [3mut. Taking into ac-
count that the molecular mass of BSA is roughly twice that
of Pmut (66.2 versus 26.4 kD), and that there is a linear re-
lationship between the mass ofboundprotein and the mea-
sured RU (35), it is apparent that both proteins give similar
nonspecific effects on the bulk refractive index. When BSA
was injected over a surface with SEC1, the signals were sim-
ilar to those in Fig. 2 C, and much lower than the responses
to equivalent masses of (3mut (Fig. 1 B).
The specific binding of (3CHO and [3mut to immobi-
lized SAGS was calculated as the difference between the re-
sponses on the SAG-derivatized and control surfaces. Plots
ofthese data indicated that the binding of [3 chain to SEC1,
SEC2, SEC3, and SPEA was saturable, as shown in Fig. 3,
A and C for the interaction of Pmut with SECl and SPEA,
respectively. A Scatchard plot for the binding of [smut to
SEC1 was linear (correlation coefficient [r] = 0.99) and
gave a KD of 19.8 [,M. The predicted maximum specific
binding was 1980 RU, while the amount of immobilized
SEC1 was 2050 RU. Since SEC1 and Pmut have similar
molecular masses (27.5 and 26.4 kD, respectively), this in-
dicates that nearly all the SEC1 and Pmut in the assay were
available for binding. The results for SPEA are shown in
Fig. 3, C and D; a KD of6.2 NLM was obtained. Similar anal-
yses were carried out for the binding of Pmut to SEC2 and
SEC3, and for the binding of [3CHO to SEC1, SEC2, and
SEC3.
The results of these experiments are summarized in Ta-
ble 1. The apparent KDs for the binding of Pmut to SEC1,
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SEC2, SEC3, and SPEA were 19.8, 7.9, 9.2, and 6.2 N,M,
respectively. For the binding of [3CHO to SEC1, SEC2,
and SEC3, the KDs were 18.2, 5.4, and 8.5 N.M. These
results demonstrate that (a) the affinity of recombinant
V[38.2J(32.1C[31 chain for SEC or SPEA is similar to those
ofsome other T cell surface glycoproteins for their ligands,
such as the adhesion molecule CD2 for CD58 and CD48
(25, 26), or of TCRs for peptide/MHC (12, 17, 37, 38)
and (b) glycosylation does not significantly contribute to
the SAG-binding activity of at least this particular R chain.
14.3 .d i6 Chain Binds SEB with Much Lower Affinity than
SEC and SPEA. The markedly weaker binding of Pmut
to SEB than to SEC1 suggested in Fig. 1, C and F was con-
firmed by equilibrium binding experiments (Fig. 4). BIA-
core measurements were carried out as described above for
SEC and SPEA, except that much higher concentrations of
[3 chain (up to 256 p,M) were required to approach satura-
tion. The Scatchard plot was linear (r = 0.97) and gave a
KD of 144 p,M with predicted maximum binding of 2460
RU (Fig. 4 D). Given that about 2700 RU of SEB were
immobilized, and that SEB and Pmut have similar molecu-
lar masses (28.5 and 26.4 kD, respectively), this indicates
that >90% ofthe coupled SAG retained binding activity.
The weak binding of SEB to the 14.3.d [3 chain was un-
expected, particularly in view ofthe finding that, on a mo-
lar basis, this toxin was actually 3- to 10-fold more effective
than SEC or SPEA in stimulating the parental 14.3 .d T cell
hybridoma (Fig. 5). We therefore decided to check our re-
sults by an independent technique, sedimentation equilib-
rium. A major advantage of this method is that both inter-
acting species are in solution, thereby avoiding any possible
artefacts arising from ligand immobilization.
The Much Weaker Binding of 0 chain to SEB than to SEC or
SPEA Is Confirmed by Sedimentation Equilibrium. Before
analysis ofthe equilibrium constants for the [3mut chain with
the various bacterial SAGS, the behavior of the individual
receptor fragment and toxins was evaluated in separate sed-
imentation experiments. All of the species under consider-
ation were well behaved, showing virtually no tendency to
aggregate at concentrations up to -25 ~LM. An estimate for
the molecular weight of the [3 chain was 28,800, in good
agreement with that expected from its amino acid compo-
sition (26,400) . The molecular weight of SEC3 was deter-
mined to be 28,300, compared with ari expected value of
28,900. Similar agreement was obtained for SEC1, SEC2
and SEB. However, the molecular weight of SPEA was es-
timated at only 22,500, somewhat lower than the expected
value of 25,800.
The equilibrium dissociation constants determinedby sedi-
mentation equilibrium for Pmut with various SAGS are
presented in Table 1 ; a representative sedimentation profile
is shown in Fig. 6 . As can be seen in Table 1, the interac-
tion of the (3 chain with virtually all the toxins occurs with
KDs in the low micromolar range (0.9-2.5 p,M). An excep-
tion is SEB, for which an estimate for the KD of only 70
p,M could be made. However, this estimate should be con-
sidered only a lower limit for the actual KD since, under the
feasible conditions for this measurement in the ultracentri-fuge, weaker binding would not have been detected. At-
tempts to better define the KD using 5- and 10-fold higher
protein concentrations (up to 0.1 mM) to favor complex
formation in this weakly interacting system were unsuc-
cessful due to problems of nonspecific aggregation at these
concentrations. It is nevertheless apparent that the SEB binds
the 14.3.d (3 chain with much lower affinity than SEC or
SPEA, in agreement with the results from BIAcore.
A comparison ofapparent KD values obtained by sedimen-
tation equilibrium with those from BIAcore reveals that the
latter are consistently higher, by up to a factor of 11 in the
case ofSPEA (Table 1) . We believe that the sedimentation
equilibrium values more accurately reflect the true binding
constants because this method does not involve chemical
coupling ofligands to a solid support. In extreme cases (e.g.,
26), immobilization can result in complete loss of binding
activity, as we observed for (3 chain coupled to the dextran
matrix (see above). Such experiences strongly suggest that
intermediate effects on ligand activity are also possible. In-
deed, we attribute the generally weaker binding of (3 chain
to SAGS measured by BIAcore than by sedimentation equi-
librium to subtle effects on SAG conformation/accessibility
arising from the immobilization procedure. These results il-
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Figure 2.
￿
Binding of 14.3.d 0 chain to immobilized SECT and SPEA. (3mut was injected at the indicated concentrations (N,M) over a control surface
with no protein immobilized,(A), or over ones to which SEC1 (2,050 RU) (B) or SPEA (1,350 RU) (D) had been coupled. The same concentrations of
BSA were also injected over a control surface (C). Buffer flow rates were 5 N,1/min. Equilibrium binding levels were reached within 4 s. After dissocia-
tion with HBS, residual bound protein was eluted using 10-s pulses of 10 mM HCI. Similar profiles were obtained for SEC2 and SEC3.
lustrate the importance of determining binding constants by
at least two independent techniques.
Our results demonstrate that unglycosylated 14.3.d P
chain, whose three-dimensional structure has been deter-
mined to high resolution (15), retains the SAG-binding ac-
tivities ofthe assembled, glycosylated up heterodimer. The
ability of the recombinant (3 chain to specifically bind SEB,
SEC1, SEC2, SEC3, and SPEA is consistent with the
known proliferative effects of these toxins on V(38.2-bear-
ing T cells (2, 36) ; in contrast, SEA, which does not stimu-
late cells expressing VR8.2 (2), does not bind the 14.3.d (3
chain with measurable affinity. We therefore conclude that
the structure ofthe (3 chain, as determined by x-ray crystal-
lography, represents a biologically active conformation of
this molecule, at least with respect to those regions respon-
sible for SAG recognition. However, we cannot formally
exclude the possibility that other regions of the R chain
monomer might have a different conformation when asso-
ciated with cx chain in the u(3 heterodimer.
Binding of the 14.3.d (3 chain to all five SAGS tested is
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characterized by very fast association rates (>l X 105
M-1s-1) and extremely fast dissociation rates (>0.1 s-1;
Fig. 1); the latter account for the relatively weak affinities
observed (i.e., 0.9 RM, at best, in the case ofSEC3). Rapid
dissociation kinetics have also been reported for the inter-
action of the rat cell adhesion molecules CD2 and CD48
(25), and for the binding of TCRs to peptide/MHC com-
plexes (37, 38) . For adhesion molecules, fast dissociation
rates may provide a mechanism to facilitate deadhesion, a
requirement for cell motility (26). For TCRs, on the other
hand, rapid dissociation rates would not appear to be com-
patible with the relatively stable interaction with ligand be-
lieved to be a prerequisite for signal transduction through
the TCR/CD3 complex (38, 39) . This suggests that T cell
activation by SAGS requires the participation of additional
surface molecules to stabilize the transient SAG-TCR in-
teraction, in agreement with other studies (4-8). While
class 11 MHC products have been clearly implicated in this
role (1-3, 13), recent evidence (14) indicates that other, yet
unidentified, molecules may substitute for MHC in pre-
senting SAGS to T cells (see below). Multivalent binding
arising from receptor cross-linking would also effectively
decrease the offrate (and increase the half-time) of the
TCR-SAG interaction. Alternatively, rapid dissociation rates
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RU
Figure 3 . Affinity of 14.3.d R
chain for SECT and SPEA. Plots
are from data in Fig. 2. Responses
resulting from injection of the in-
dicated concentrations of (3mut
over control surface (O, A, C),
SEC1 (O, A) and SPEA (O, C)
are shown. Specific binding (A, A,
C) was calculated as the difference
between the responses for SECT
and SPEA and the control surface.
Scatchard analysis of the specific
binding of (3mut to SECT (B) and
SPEA (D) gave linear plots with
correlation coefficients of 0.99 and
0.98, respectively. The apparent
KDs for the (3mut-SEC1 and
(3mut-SPEA reactions were 19.8
and 6.2 N.M, respectively.
may actually be critical for T cell triggering by SAGS, as sug-
gested by a recent study in which a single peptide/MHC
complex was found to be able to sequentially bind and trig-
ger nearly 200 TCRs (40).
The complexity of TCR-SAG interactions is further il-
lustrated by the finding that a soluble human TCR express-
ing the VR3.1 gene segment binds SAGS with quite differ-
ent kinetics than the mouse VR8.2 TCR described here (12).
Binding of the human VR3.1 TCR to SEB is characterized
by association and dissociation rates which are only moder-
ately fast: 1 .3 X 104 M-1s-1 and 1 .1 X 10-2 s-1 , respec-
tively. The affinity of this TCR for SEB, however, is com-
parable to that of the 14.3.d R chain for SEC3: 0.8 p,M
versus 0 .9 pLM, respectively. On the other hand, SEB was
shown to bind HLA-DR1 with kinetics very similar to those
we observe for the V08.2-SAG interaction (12) ; in both
cases, the association and dissociation rates were too rapid
to be accurately measured. This implies that binding ofhu-
man V(33.1 to SEB helps stabilize the transient SEB-DR1 in-
teraction and, consequently, the TCR-SEB-DR1 complex
(12) . We might therefore expect the binding of murine
VR8.2 to SEB to be stabilized by a more kinetically favorable
interaction of SEB with class 11 molecules (i.e., one with a
slower dissociation rate).3000
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Figure 4.
￿
Binding of 14.3.d (3 chain to immobilized SEB. (3mut was injected at the indicated concentrations (11M) over a control surface with no pro-
tein immobilized (A) or one with 2,700 RU SEB (B). Buffer flow rates were 5 NU/min; equilibrium binding levels were reached within 4 s. After disso-
ciation, residual protein was eluted using 10-s pulses of 10 mM HCI. Specific binding (A, C) was calculated as the difference between the total response
(O) and the non-specific response (O). The Scatchard plot was linear (r = 0.97) and gave a KD of 144 ltM.
The much weaker binding of the 14.3.d (3 chain, or of
aR heterodimer, to SEB than to SEC1, SEC2, SEC3 or
SPEA was surprising, since all five toxins are known to stim-
ulate V(38.2-bearing T cells (2, 36). Furthermore, SEB was
considerably more potent than the other toxins in stimula-
tion assays using the 14.3.d hybridoma (Fig. 5). These re-
sults may be interpreted in terms of a recent study describ-
ing functional differences between SEB and SEC in MHC
class II knockout mice (14) . Incubation oflymph node cells
from class II-deficient mice with SEC, but not SEB, resulted
in the clonal expansion ofVP8-positive T cells and the gen-
eration of CTL. Similar results were obtained with SEE,
except that V(311-positive cells were selectively expanded.
The responses to SEC and SEA resembled conventional
MHC-associated responses in that T cell bearing the same
V(3 elements were specifically affected. Our data provide a
c
0
G
1840
￿
Superantigen Binding to TCR 13 Chain
12E
64
32
16
1000 2000 3000 4000
Time (s)
straightforward explanation for the finding that activation
ofV(38-positive T cells by SEC can occur in the absence of
MHC, in contrast to activation by SEB: whereas SEC1, 2,
and 3 bind the 14.3.d R chain with Kps of0.9-2.5 p,M, the
corresponding value for SEB is between 70 and 140 1LM
(Table 1). Thus, SEs able to bind TCRs with micromolar
affinities may not absolutely require the participation ofMHC
class II molecules to stabilize their interaction with the R
chain. Even in the case of MHC-independent activation,
however, APC from MHC class II-deficient mice (or from
mice lacking both class I and class II) were required for
stimulation (14). This suggests that other surface molecules
may substitute for MHC in binding certain SEs, and per-
haps also the TCR, thereby helping to stabilize TCR-SE
interactions.
A further distinction between SEB and SEC may lie in60
50-
20-
10 -I
0
U(SEB)
U(SECI)
U(SEC2)
ng/ml
U(SEC3)
U(SPEA)
U(SEA)
Figure 5.
￿
IL-3 production by the parental 14 .3.d hybridoma after stim-
ulation with different SAGS in the presence ofA20 APC. The SAG con-
centrations used are as indicated with the different symbols .
their relative affinities forMHC class II . While SEB has been
shown to bind HLA-DR1 and -DQ with aKDs in the mi-
cromolar range (9-11), the data on SEC is less clear . In one
study, SEC2 was found able to compete with SEB for
Table 1 .
￿
Dissociation Constantsfor the Binding ofBacterial
Toxins to Glycosylated and Unglycosylated 14.3.d /3 Chain
Affinity measurements by BIAcore and sedimentation equilibrium
were carried out as described in Materials and Methods . All experi-
ments were performed at 25°C using the molecular weight values pre-
sented in the text and the specific extinction coefficients provided by
Toxin Technology, Inc . The value for the association of SEB with
Rmut obtained from sedimentation equilibrium is a lower limit for the
dissociation constant . NB, no detectable binding ; ND, notdone .
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Figure 6.
￿
Sedimentation equilibrium of an equimolar mixture of the
14 .3.d R chain with SECT . Sedimentationwas performed at 22,000 rpm
in 50 mM Tris-HCI,pH 8.0, at 25°C. Starting concentrations of (3 chain
and SEC1 were 7.5 p.M . (Bottom) Absorbance at 280 nm versus distance
from the center of rotation in centimeters . (Top) The residuals (AZ80
theoretical - AZ8o  observed) for the equilibrium between the two
components, yielding aKpof2.51 p.M, are small andrandom . Similar re-
sults were obtained for SEC2, SEC3, andSPEA .
binding to 1311,1-positive B cells (41), whereas in another
study no binding ofSEC1 to cells expressing DR3,5 could
be demonstrated (42) . Indeed, the differential association of
certain SAGS with different class II molecules has been put
forward as a possible explanation for the lack ofan absolute
correlation between V(3 expression and SAG reactivity (13),
40-M
Figure 7.
￿
Space-filling model of the 14 .3.d i3 chaia showing the loca-
tion of potential N-linked glycosylation sites . The V(3 and Ci3 domains
are labeled; CDRl (residues 25-33) is shown in green, CDR2 (residues
48-56) in purple, andHV4 (residues 69-75) in lightbrown . TheN-linked
glycosylation sites at VP positions 24 and 74 and at C(3 position 236 are
labeled 1, 2, and 3, respectively . Those at C(3 positions 121 and 186 are
not visible in this orientation .
SAG
oc
BIAcore
RCHO
BIAcore
(X 10-6 M)
(3mut
BIAcore
(X 10-6 M)
Rmut
Centrifuge
(X 10-6M)
SEC1 NB 18.2 19.8 2.51
SEC2 NB 5.4 7.9 2.32
SEC3 N13 8.5 9.2 0.86
SPEA NB ND 6.2 2.11
SEB NB ND 144 >70
SEA NB NB NB NDFigure 8 . Space-filling model ofthe putative SAG-binding face ofthe V(38.2 domain showing the location of conserved residues relative to Vpl, V(33,
V(37, and V(311 . The amino acid sequences ofVP segments 1, 3, 7, and 11 were aligned with that ofV(38.2 according to reference 21 ; no insertions or
deletions with respect to V(38 .2 were present. V(38 .2 residues which are conserved relative to each ofthe other V(3 segments are shown in red in the pan-
els marked Vp1, V/33, V(37, and V(311 . CDR1 is in green, CDR2 in purple, andHV4 in light brown . The potential N-linked glycosylation sites at V(38 .2
positions 24 and 74 are in gray; neither site is conserved in any of the other V(3 segments . Single-letter abbreviations for amino acid residues are : E, Glu ;
I, Ile ; K, Lys; L, Leu ; N, Asn ; P, Pro ; Q, Gln ; R, Arg; S, Set ; T, Thr ; and V, Val .
While no affinities have been reported for the interaction
ofSAGs with mouse class 11 proteins, it tempting to specu-
late that the very weak binding of SEB to VR8.2 we ob-
serve is compensated by a fairly strong association between
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SEB and mouse class 11, hence accounting for the fact that
T cell activation by SEB requires MHC (6) . Conversely,
SEC, even though it may lack appreciable affinity formouse
class 11, binds V(38.2 sufficiently tightly to enable it to stim-ulate T cells independently of MHC. Yet a third scenario is
suggested by SEB, which binds both human VR3.1 and
DR with micromolar affinities (12) . Thus, the same en-
terotoxin may activate different T cells by different mecha-
nisms, depending on the particular VP element they express
and on the specific MHC background of the host.
As shown in Table 1, glycosylated 14.3 .d R chain binds
SEC1, 2, and 3 with essentially the same affinity as unglyc-
osylated R chain. This indicates that carbohydrate does not
contribute to SAG binding, at least in this particular case.
This result is somewhat surprisingsince the potential N-linked
glycosylation sites at VP residues Asn24 and Asn74, which
were mutated to glutamine (15), are at or near the putative
SAG binding site in the three-dimensional structure of the
R chain (Fig. 7) . In particular, Asn74 is part of the so called
fourth hypervariable region (HV4), which has been directly
implicated in SAG recognition (3), while Asn24 would be
expected to lie adjacent to Asn74 in the unmutated structure.
One explanation for the lack of effect of mutations at these
positions is that neither Asn24 nor Asn74 is actually glyco-
sylated. We consider this unlikely, as both residues are lo-
cated on the surface of the protein. Alternatively, these resi-
dues may in fact lie at the periphery of the combining site
for bacterial SAGs. It is worth noting in this respect that
mutation of Asn24 to glutamate has been shown to confer
reactivity to Us-1 (43) . This suggests that viral and bacterial
SAGs bind somewhat different regions of the VP domain.
To investigate the structural basis for the SAG-binding
specificity of different R chains, pairwise comparisons were
carried out between mouse V08.2 and Vol, V03, VP7,
and VR11 based on the crystal structure of the VR8.2 do-
main (Fig. 8) . While VR3, VR7, VR8.2, and VP 11 all react
with SEC (and VR3, VR7, and VR8.2 react with SEB as
well), Vol does not react with either SEB or SEC, but
only with SEA, which does not bind VR8.2 (2). As might
be expected, a comparison of conserved residues on the
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putative SAG-binding face of the VR8.2 domain reveals
that Vol indeed has fewer residues in common with VR8.2
than do VR3, VR7, or VR11 . Excluding residues unlikely
to be involved in direct contacts with bacterial SAGS be-
cause they lie at the periphery of this surface (Thr5, Arg9,
Va112, Asn30, Pro110, Arg113, and Leu116a), VR8.2
shares five residues with VR3 (Pro8, Lys18, Pro70, Ser71,
and Ser76), five residues with VR7 (Va119, Ser68, Glu73,
Ser76, and Ileu78), five residues with VR11 (Pro8, Lys11,
Thr20, Pro70, and Gln72), but only three residues with
Vol (Ser7, Pro8, and Pro70). What is remarkable, how-
ever, is that even between VR8 .2 and VR3, VR7, or Vol 1,
all ofwhich react with a similar spectrum of SAGS, the num-
ber of common residues is relatively small; furthermore,
these residues are not particularly concentrated in HV4.
This indicates that certain SAGs (SEC3, for example, which
reacts with VR3, VR7, and VR8.2) are able to recognize
very different molecular surfaces present on different VP
domains. One way this could occur is if a single SAG pos-
sessed several distinct VR-binding sites. However, a recent
x-ray crystallographic study of an idiotope--anti-idiotope
complex (44) suggests that it is not necessary to postulate
multiple binding sites to explain the recognition of topo-
graphically different surfaces by a single molecular species.
In this study, the contacts made between an anti-lysozyme
antibody (D1 .3) and an anti-idiotopic antibody (E5.2) raised
against it were compared with the contacts made between
D1 .3 and lysozyme in the original antigen-antibody com-
plex (45). Surprisingly, it was found that D1 .3 employed
essentially the same set ofcombining site residues (and most
of the same atoms) in binding lysozyme as in binding E5.2,
despite the fact that the sites on lysozyme and E5.2 recog-
nized by 131 .3 were structurally unrelated. Whether similar
mechanisms operate to permit individual SAGs to interact
with a number of different VP families must await direct
structural studies of R chain-SAG complexes.
Address correspondence to Dr. Roy A. Mariuzza, Center for Advanced Research in Biotechnology, 9600
Gudelsky Drive, Rockville, MD 20850.
Receivedforpublication 11 May 1995 and in revisedform 10July 1995.
Note added in proof . Since this manuscript was submitted, we have determined the crystal structure of a com-
plex between the 14.3.d R chain and SEC3. Superantigen contacts are mainly with CDR1, CDR2, and
HV4, rather than with framework residues. The glycosylation sites at V(3 positions 24 and 74 are not directly
implicatedin the R chain-SEC3 interface.
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